Ocean global warming tool sinks

Written byAlison McCook

| 1 min read

A company that aimed to reduce global warming by creating blooms of carbon dioxide-absorbing phytoplankton in the ocean has sunk, linkurl:according to;http://www.nytimes.com/2008/02/14/technology/14planktos.html?_r=1&oref=slogin the New York Times. The company, Planktos, posted a linkurl:statement on its Web site;http://planktos.com/ yesterday (February 13) saying that it had decided to "indefinitely postpone its ocean fertilization efforts" as a result of a "highly effective disinformation campaign waged by anti-offset crusaders" that turned public opinion against the effort and stymied attempts to raise capital to conduct ocean research trials. Our columnist linkurl:Glenn McGee;http://www.the-scientist.com/2007/11/1/33/1/ wrote about the company's efforts in our November, 2007 issue. The plan has been met with strong resistance from the scientific community, many of whom debunked or dismissed the company's claims. Planktos has called back its research vessel from the Portuguese island of Madeira, and "radically downsized" the staff. "The board of directors continues to believe in the urgent ecological necessity of its ocean restoration plans and the scientific speciousness of objections voiced to date. However, ideological hostility to and misrepresentations of this work will continue to stymie progress until the true gravity of our climatic and ocean crises is more widely understood." In November, a company representative sent a note to The Scientist complaining that a column by Glenn McGee and a linkurl:follow-up blog;http://www.the-scientist.com/blog/display/53848/ had dubbed the company's technology "nanotech." "I am unsure where this information originated, but we are not employing nanotechnology of any kind for our work," said Sarah Kelly, outreach doordinator at Planktos.

Ocean global warming tool sinks

The Scientist ARCHIVES

Become a Member of

Meet the Author

Alison McCook

Related Research Resources

A Stubborn Gene, a Failed Experiment, and a New Path

Research Resources

Podcasts

Webinars

Videos

Infographics

eBooks

Advancing Drug Discovery with Complex Human In Vitro Models

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Maximizing Cancer Research Model Systems

Products

Product News

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies